Monday, November 26 | 11:20 a.m.-11:30 a.m. | RC215-14 | Arie Crown Theater
In this talk, researchers will report that the concurrent use of artificial intelligence (AI) software while interpreting digital breast tomosynthesis (DBT) screening exams leads to higher radiologist accuracy and much faster reading times.Adding DBT to full-field digital mammography has been shown to lower recall rates and improve cancer detection; however, it takes significantly longer to read a DBT study, according to presenter Dr. Emily Conant of the Hospital of the University of Pennsylvania in Philadelphia. The researchers sought to determine whether AI software from iCAD -- currently pending U.S. Food and Drug Administration clearance -- could reduce reading time in interpreting DBT studies while maintaining or improving radiologist performance.
In a reader study involving 24 radiologists reading 260 DBT cases both with and without AI, the radiologists realized a 5.7% improvement in the area under the receiver operating characteristic curve, an 8% increase in sensitivity, a 6.9% increase in specificity, and a 7.2% reduction in recall rate with the use of AI. What's more, reading times were shortened by 52.7%.
"Therefore, reading 2D [mammography] plus DBT with AI improved the readers' performance while also reducing reading time compared to reading without AI," Conant told AuntMinnie.com.
Get all the details by attending this Monday morning presentation.












![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






